“If there's an EUA or approval, CytoDyn would never need to raise capital ever again. Preferred stock would be pointless.”

100% agree and NP has the same mindset. He has agreed to the Fife deals over the last 6 months because approval for the S/C population would eliminate the need for fundraising. The EIND data, documented in multiple publications, points strongly to a pending COVID approval.